Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Elevidys
Pharma
Sarepta's Elevidys blows sales expectations out of the water
Elevidys' $181 million sales in the third quarter beat analysts' expectations as it made a 48% sequential leap.
Kevin Dunleavy
Nov 7, 2024 3:43pm
Roche's Vabysmo will rise above Eylea biosim threat, exec says
Oct 23, 2024 11:24am
Sanofi sues Sarepta over 2 gene therapy manufacturing patents
Jul 30, 2024 5:21pm
FDA broadens label for Sarepta's Duchenne gene therapy Elevidys
Jun 21, 2024 7:51am
Pfizer's DMD loss is Sarepta's gain: analysts
Jun 13, 2024 10:58am
Italfarmaco wins FDA's blessing for nonsteroidal DMD therapy
Mar 22, 2024 11:05am
